Invention Grant
- Patent Title: Inhibitors of plasma kallikrein and uses thereof
-
Application No.: US16299996Application Date: 2019-03-12
-
Publication No.: US10730874B2Publication Date: 2020-08-04
- Inventor: Nikolaos Papaioannou , Sarah Jocelyn Fink , Thomas Allen Miller , Gerald Wayne Shipps, Jr. , Jeremy Mark Travins , David Edward Ehmann , Alastair Rae , John Mark Ellard
- Applicant: Shire Human Genetic Therapies, Inc.
- Applicant Address: US MA Lexington
- Assignee: Shire Human Genetic Therapies, Inc.
- Current Assignee: Shire Human Genetic Therapies, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Choate, Hall & Stewart LLP
- Agent John P. Rearick; Cristin E. Juda
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00 ; A61P9/00 ; A61P29/00
Abstract:
The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
Public/Granted literature
- US20190284182A1 INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF Public/Granted day:2019-09-19
Information query
